Search details
1.
Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials.
Osteoporos Int
; 2024 Apr 04.
Article
in English
| MEDLINE | ID: mdl-38573517
2.
A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density.
Osteoporos Int
; 34(11): 1893-1906, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37495683
3.
Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates-a real-world cohort study.
Osteoporos Int
; 33(6): 1323-1334, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35080633
4.
The predictive value of bone turnover markers during discontinuation of alendronate: the PROSA study.
Osteoporos Int
; 32(8): 1557-1566, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-33517477
5.
Fracture rates in patients discontinuing alendronate treatment in real life: a population-based cohort study.
Osteoporos Int
; 32(6): 1103-1115, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33411002
6.
Fragility fractures and health-related quality of life: does socio-economic status widen the gap? A population-based study.
Osteoporos Int
; 32(1): 63-73, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32681362
7.
The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.
Osteoporos Int
; 32(1): 185-191, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33030563
8.
Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis.
Osteoporos Int
; 32(1): 173-184, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33200257
9.
Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis.
Osteoporos Int
; 32(9): 1879-1888, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-33606045
10.
Socio-economic inequalities in fragility fracture incidence: a systematic review and meta-analysis of 61 observational studies.
Osteoporos Int
; 32(12): 2433-2448, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34169346
11.
Socio-economic inequalities in fragility fracture outcomes: a systematic review and meta-analysis of prognostic observational studies.
Osteoporos Int
; 31(1): 31-42, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31471664
12.
A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab.
Osteoporos Int
; 31(11): 2231-2241, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32623487
13.
Glucose-Lowering Drugs and Fracture Risk-a Systematic Review.
Curr Osteoporos Rep
; 18(6): 737-758, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33165875
14.
Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis.
Osteoporos Int
; 30(5): 995-1002, 2019 May.
Article
in English
| MEDLINE | ID: mdl-30656367
15.
Do femoral fractures in adult patients with osteogenesis imperfecta imitate atypical femoral fractures? A case series.
Osteoporos Int
; 30(2): 513-517, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30448959
16.
Osteogenesis imperfecta and the teeth, eyes, and ears-a study of non-skeletal phenotypes in adults.
Osteoporos Int
; 29(12): 2781-2789, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30143849
17.
Local bone loss in patients with anti-citrullinated peptide antibody and arthralgia, evaluated with high-resolution peripheral quantitative computed tomography.
Scand J Rheumatol
; 47(2): 110-116, 2018 Mar.
Article
in English
| MEDLINE | ID: mdl-28832223
18.
Temporomandibular disorders and psychosocial status in osteogenesis imperfecta - a cross-sectional study.
BMC Oral Health
; 18(1): 35, 2018 03 07.
Article
in English
| MEDLINE | ID: mdl-29514671
19.
Hypercalcemia after discontinuation of long-term denosumab treatment.
Osteoporos Int
; 27(7): 2383-2386, 2016 07.
Article
in English
| MEDLINE | ID: mdl-27098536
20.
Skeletal phenotypes in adult patients with osteogenesis imperfecta-correlations with COL1A1/COL1A2 genotype and collagen structure.
Osteoporos Int
; 27(11): 3331-3341, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27256333